EN
抗体药类似物
Research Grade Tilogotamab
All
  • CatalogTD-HT348066
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsGEN-1029,HexaBody-DR5/DR5,Hx-DR5-01/05,CAS:2109731-10-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Tilogotamab


Catalog No. TD-HT348066
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O14763
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names GEN-1029,HexaBody-DR5/DR5,Hx-DR5-01/05,CAS:2109731-10-2
Background Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HT348066_1.jpg
标题
 
Detects CD262/TNFRSF10B/TRAIL-R2/DR5 in indirect ELISAs.